Conformational equilibria in monomeric alpha-synuclein at the single molecule level

Natively unstructured proteins defy the classical "one sequence-one structure" paradigm of protein science. Monomers of these proteins in pathological conditions can aggregate in the cell, a process that underlies socially relevant neurodegenerative diseases such as Alzheimer and Parkinson. A full comprehension of the formation and structure of the so-called misfolded intermediates from which the aggregated states ensue is still lacking. We characterized the folding and the conformational diversity of alpha-synuclein (aSyn), a natively unstructured protein involved in Parkinson disease, by mechanically stretching single molecules of this protein and recording their mechanical properties. These experiments permitted us to directly observe directly and quantify three main classes of conformations that, under in vitro physiological conditions, exist simultaneously in the aSyn sample, including disordered and "beta-like" structures. We found that this class of "beta-like" structures is directly related to aSyn aggregation. In fact, their relative abundance increases drastically in three different conditions known to promote the formation of aSyn fibrils: the presence of Cu2+, the occurrence of the pathogenic A30P mutation, and high ionic strength. We expect that a critical concentration of aSyn with a "beta-like" structure must be reached to trigger fibril formation. This critical concentration is therefore controlled by a chemical equilibrium. Novel pharmacological strategies can now be tailored to act upstream, before the aggregation process ensues, by targeting this equilibrium. To this end, Single Molecule Force Spectroscopy can be an effective tool to tailor and test new pharmacological agents.

[1]  Jane Clarke,et al.  Mechanical unfolding of proteins: insights into biology, structure and folding. , 2007, Current opinion in structural biology.

[2]  Carlos Bustamante,et al.  Grabbing the cat by the tail: manipulating molecules one by one , 2000, Nature Reviews Molecular Cell Biology.

[3]  S E Ide,et al.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. , 1997, Science.

[4]  A. Bax,et al.  Comparison of Structure and Dynamics of Micelle-bound Human α-Synuclein and Parkinson Disease Variants* , 2005, Journal of Biological Chemistry.

[5]  V. Uversky,et al.  Protein Misfolding, Aggregation, and Conformational Diseases , 2006 .

[6]  L. Serpell,et al.  Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[7]  E. Bergantino,et al.  Structure and topology of the non-amyloid-beta component fragment of human alpha-synuclein bound to micelles: implications for the aggregation process. , 2006, Protein science : a publication of the Protein Society.

[8]  Min Zhu,et al.  Alpha-synuclein can function as an antioxidant preventing oxidation of unsaturated lipid in vesicles. , 2006, Biochemistry.

[9]  V. Subramaniam,et al.  NMR of α‐synuclein–polyamine complexes elucidates the mechanism and kinetics of induced aggregation , 2004, The EMBO journal.

[10]  Matthias Rief,et al.  Elastically Coupled Two-Level Systems as a Model for Biopolymer Extensibility , 1998 .

[11]  Michele Vendruscolo,et al.  Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases. , 2005, Journal of molecular biology.

[12]  S. Lindquist,et al.  α-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson's Models , 2006, Science.

[13]  A. Fink Natively unfolded proteins. , 2005, Current opinion in structural biology.

[14]  C. Dobson,et al.  Protein misfolding, functional amyloid, and human disease. , 2006, Annual review of biochemistry.

[15]  M. Rief,et al.  Single molecule force spectroscopy of spectrin repeats: low unfolding forces in helix bundles. , 1999, Journal of molecular biology.

[16]  M. Blackledge,et al.  Defining long-range order and local disorder in native alpha-synuclein using residual dipolar couplings. , 2005, Journal of the American Chemical Society.

[17]  Dan S. Tawfik,et al.  Conformational diversity and protein evolution--a 60-year-old hypothesis revisited. , 2003, Trends in biochemical sciences.

[18]  V. Uversky,et al.  Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure. , 2001, The Journal of biological chemistry.

[19]  Matthias Rief,et al.  Sensing specific molecular interactions with the atomic force microscope , 1995 .

[20]  J. Walker,et al.  Over-production of proteins in Escherichia coli: mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels. , 1996, Journal of molecular biology.

[21]  Wolfgang A. Linke,et al.  Reverse engineering of the giant muscle protein titin , 2002, Nature.

[22]  A. Ulman,et al.  Formation and Structure of Self-Assembled Monolayers. , 1996, Chemical reviews.

[23]  N. Maiti,et al.  Raman spectroscopic characterization of secondary structure in natively unfolded proteins: alpha-synuclein. , 2004, Journal of the American Chemical Society.

[24]  Luca Pinato,et al.  A topological model of the interaction between alpha-synuclein and sodium dodecyl sulfate micelles. , 2005, Biochemistry.

[25]  M. Saraste,et al.  States and transitions during forced unfolding of a single spectrin repeat , 2000, FEBS letters.

[26]  M. Hegner,et al.  Formation and in Situ Modification of Monolayers Chemisorbed on Ultraflat Template-Stripped Gold Surfaces , 1995 .

[27]  Andres F. Oberhauser,et al.  The molecular elasticity of the extracellular matrix protein tenascin , 1998, Nature.

[28]  Leonidas Stefanis,et al.  Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. , 2004, Science.

[29]  Jie Li,et al.  The Association of α-Synuclein with Membranes Affects Bilayer Structure, Stability, and Fibril Formation* , 2003, Journal of Biological Chemistry.

[30]  Biophysical investigations of engineered polyproteins: implications for force data. , 2005, Biophysical journal.

[31]  E. Siggia,et al.  Entropic elasticity of lambda-phage DNA. , 1994, Science.

[32]  A. Oberhauser,et al.  Single protein misfolding events captured by atomic force microscopy , 1999, Nature Structural Biology.

[33]  A. Fink,et al.  Characterization of oligomers during alpha-synuclein aggregation using intrinsic tryptophan fluorescence. , 2006, Biochemistry.

[34]  V. Subramaniam,et al.  Impact of the acidic C-terminal region comprising amino acids 109-140 on alpha-synuclein aggregation in vitro. , 2004, Biochemistry.

[35]  P. Lansbury,et al.  Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[36]  H. Dyson,et al.  Intrinsically unstructured proteins and their functions , 2005, Nature Reviews Molecular Cell Biology.

[37]  G Zuccheri,et al.  Protein unfolding and refolding under force: methodologies for nanomechanics. , 2005, Chemphyschem : a European journal of chemical physics and physical chemistry.

[38]  F. Valle,et al.  The interplay between chemistry and mechanics in the transduction of a mechanical signal into a biochemical function , 2007, 0705.2706.

[39]  P. Lansbury,et al.  Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. , 2000, Biochemistry.

[40]  J. Toca-Herrera,et al.  Versatile cloning system for construction of multimeric proteins for use in atomic force microscopy , 2002, Protein science : a publication of the Protein Society.

[41]  K. Schulten,et al.  Unfolding of titin immunoglobulin domains by steered molecular dynamics simulation. , 1998, Biophysical journal.

[42]  C. Griesinger,et al.  Structural characterization of copper(II) binding to alpha-synuclein: Insights into the bioinorganic chemistry of Parkinson's disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[43]  R. Krüger,et al.  Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. , 1998, Nature genetics.

[44]  Harry B Gray,et al.  Alpha-synuclein structures from fluorescence energy-transfer kinetics: implications for the role of the protein in Parkinson's disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. Hoenicka,et al.  The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia , 2004, Annals of neurology.

[46]  M. Nilges,et al.  Pathways and intermediates in forced unfolding of spectrin repeats. , 2002, Structure.

[47]  C. Dobson,et al.  Mapping long-range interactions in alpha-synuclein using spin-label NMR and ensemble molecular dynamics simulations. , 2005, Journal of the American Chemical Society.

[48]  C. Griesinger,et al.  Interaction of alpha-synuclein with divalent metal ions reveals key differences: a link between structure, binding specificity and fibrillation enhancement. , 2006, Journal of the American Chemical Society.

[49]  K. Schulten,et al.  Single-Molecule Experiments in Vitro and in Silico , 2007, Science.

[50]  Vladimir N Uversky,et al.  Conformational behavior of human alpha-synuclein is modulated by familial Parkinson's disease point mutations A30P and A53T. , 2002, Neurotoxicology.

[51]  G J Pielak,et al.  Solvent-induced collapse of alpha-synuclein and acid-denatured cytochrome c. , 2001, Protein science : a publication of the Protein Society.

[52]  V. Daggett,et al.  Can non-mechanical proteins withstand force? Stretching barnase by atomic force microscopy and molecular dynamics simulation. , 2001, Biophysical journal.

[53]  P. Nelson,et al.  Volume-exclusion effects in tethered-particle experiments: bead size matters. , 2005, Physical review letters.

[54]  E. Capriotti,et al.  Hierarchical Mechanochemical Switches in Angiostatin , 2006, Chembiochem : a European journal of chemical biology.

[55]  K. Jellinger,et al.  The role of alpha-synuclein in the pathogenesis of multiple system atrophy. , 2005, Acta neuropathologica.

[56]  Chad Ray,et al.  Conformational heterogeneity of surface-grafted amyloidogenic fragments of alpha-synuclein dimers detected by atomic force microscopy. , 2005, Journal of the American Chemical Society.

[57]  A. Oberhauser,et al.  Mechanical design of proteins studied by single-molecule force spectroscopy and protein engineering. , 2000, Progress in biophysics and molecular biology.

[58]  M. Zweckstetter,et al.  Correlation of Amyloid Fibril β‐Structure with the Unfolded State of α‐Synuclein , 2007, Chembiochem : a European journal of chemical biology.

[59]  Hongbin Li,et al.  Sub-angstrom conformational changes of a single molecule captured by AFM variance analysis. , 2006, Biophysical journal.

[60]  S. Lindquist,et al.  A natively unfolded yeast prion monomer adopts an ensemble of collapsed and rapidly fluctuating structures , 2007, Proceedings of the National Academy of Sciences.

[61]  V. Uversky,et al.  Conformational behavior and aggregation of alpha-synuclein in organic solvents: modeling the effects of membranes. , 2003, Biochemistry.

[62]  C. Griesinger,et al.  Familial mutants of alpha-synuclein with increased neurotoxicity have a destabilized conformation. , 2005, Journal of Biological Chemistry.

[63]  M. Rief,et al.  Reversible unfolding of individual titin immunoglobulin domains by AFM. , 1997, Science.

[64]  Peter T. Lansbury,et al.  Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease , 1998, Nature Medicine.

[65]  C. Griesinger,et al.  Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein. , 2005, Proceedings of the National Academy of Sciences of the United States of America.